Pharmaceutical IT Spending in Italy to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Key Pharma News 15 DECEMBER 2014

Key Pharma News 15 DECEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 29 pages

Industry Trend Analysis - Merck Claims Leadership Of Revived Antibiotics Market With Cubist Acquisition Industry Trend Analysis - Pfizer Will Become Serious Contender In Immuno-Oncology Industry Brief - UCB/Daiichi Sankyo To Jointly Commercialise Lacosamide In Japan Industry Brief - Evotec/Sanofi In ...

Industries: Drug and Medication | Countries: South Korea, United States, Japan, World, Canada, Italy, China, Europe

Anti-Infective Drug News 08 DECEMBER 2014

Anti-Infective Drug News 08 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - Drugmakers Undertake Risks To Enable Ebola Vaccines To Reach Market Faster Industry Brief - FDA Approves Onexton Gel For Acne Vulgaris Industry Brief - Dificlir Proven To Be Clinically/Cost Effective Over SoC Treatments In CDI Industry Brief - Basilea Launches Zevtera In Germany ...

Industries: Drug and Medication | Countries: Italy, Germany, Europe

Drug Delivery Insight 01 DECEMBER 2014

Drug Delivery Insight 01 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - Adherence Concerns To Spur New Technology Introductions Industry Trend Analysis - Sights Firmly Set On Animal Health As Bayer Seeks Diabetes Exit Industry Brief - Medical Device Tax Causes B Braun To Shelve US HQ Expansion Plans Industry Trend Analysis - FDA-Approved Hysingla ...

Industries: Drug Delivery Technology | Countries: Spain, Italy, Japan, United States

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • December 2014
  • 54 pages

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023 Summary Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers in men and second highest in women. CRC is a high mortality cancer, with mortality rates just behind ...

Industries: Pathology | Countries: World, Spain, Italy, France, Germany, Japan, China

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • December 2014
  • 48 pages

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, ...

Industries: Pathology | Countries: Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe

APOGEPHA Arzneimittel GmbH SWOT Analysis, Strategy, Revenues and Profits

APOGEPHA Arzneimittel GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: Slovenia, Portugal, Italy, Ireland, Greece, Germany, Croatia, Belgium, Europe

Italfarmaco S.p.A. SWOT Analysis, Strategy, Revenues and Profits

Italfarmaco S.p.A. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Italy

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmacies and Drug Stores | Countries: Europe, Czech Republic, Germany, Sweden, Slovakia (slovak Republic), Italy, Finland, Denmark, Bulgaria, World, Switzerland, Netherlands, Norway, Hungary, Croatia, Bosnia and Herzegovina, Serbia and Montenegro

ratiopharm direct GmbH SWOT Analysis, Strategy, Revenues and Profits

ratiopharm direct GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: Germany, Spain, Italy, France

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: Czech Republic, Italy, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.